23 November 2024NewsAmericasChristina MacDougall, Partner, Morgan Lewis | Susan Evans, Senior Director, Intellectual Property, IGM Biosciences | Lawrence Rozsnyai, Vice President of Intellectual Property, Lycia Therapeutics | Reena Bajpai, Senior Counsel II, Gilead Sciences

WATCH: Strategies for success - patent drafting and application

Panellists from IGM Biosciences, Lycia Therapeutics, Gilead Sciences, and Morgan Lewis delve into how thoughtful patent drafting can improve prosecution outcomes and strengthen overall IP strategy.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Week Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com 


More on this story

Americas
17 June 2026   A cancer diagnostics company has lost its bid to overturn a jury verdict in a major patent dispute that has also spawned parallel proceedings before the Federal Circuit and PTAB.
Americas
15 June 2026   Unanimous jury finds willful infringement, with the possibility of a trebled award and a much larger feud still to come.
Americas
12 June 2026   In a strong response to BioNTech, Moderna argues its next-gen vaccine is built on a fundamentally different design from the German biotech’s—setting up a scrap over whether a key patent should have been granted.